Piraeus Bank announces that it has signed a Bancassurance Agreement with ING Group for a 10-year exclusive bancassurance distribution partnership in Greece. The new distribution partnership will cover exclusive distribution of ING life, employee benefits and pension insurance products through the Piraeus branch network in Greece and, respectively, the promotion of Piraeus Bank retail banking products from ING agent network in Greece.
In the framework of the new agreement, Piraeus Bank has transferred to ING its stake in their joint venture company, as prescribed by the new bancassurance structure in their strategic cooperation.
The new bancassurance partnership carries on the current strategic alliance agreement, which was signed in 2002 for a 5 year term.
The agreement was executed following a Memorandum of Understanding which the two parties had signed earlier in July this year.

The Ethniki, Hellenic General Insurance Company S.A. in accordance with Law.3556/30.4.2007 article 3 (ist), (bb) & 21 combined with article 11 of the Capital Market Commission decision 1/434/3.7.2007 announces that the National Bank of Greece (as legal representative according to Law 3340/10.5.2007) has acquired 2.107.056 common nominal shares (for 5,50 Euro per share and total value up to 11.588.808,00 Euro) on September 27, 2007. The shares are accompanied with voting rights in "Ethniki" and they represent 1,63% of the Company's total voting rights.
Previous to the triggering transaction the voting rights number amounted to 116.081.958 (89,91%)
After the triggering transaction the voting rights number amounts to 118.189.014 (91,54%)

Emporiki Bank of Greece S.A. informs the investment public and its shareholders that through the decision 8/445/27.9.2007 of the Capital Market Committee BoD it has been decided to:
1. Authorise the issuing company EMPORIKI BANK OF GREECE S.A. to sell 186.137 tangible nominal shares not deposited for dematerialization and shares deriving from corporate acts and issued in an intangible form in favor of the tangible shares beneficiaries.
2. Appoint EMPORIKI BANK OF GREECE S.A. as the responsible member of the Athens Stock Exchange in order to sell the shares in question. 3. Determine Tuesday, October 2nd, 2007 as the date of starting selling the shares. The shares will be sold according to the dispositions stipulated in the Decision 1/380/4.5.2006 made by the Capital Market Committee BoD and in the article 99Α of the Athens Stock Exchange regulation. Emporiki Bank will announce the result of every selling period and following the accomplishment of the relative process, it will inform its beneficiary shareholders through a letter regarding the result of selling the shares in question, the amount deposited in their account in the Loans and Consignment Fund as well as regarding the procedure, including the supporting documents needed, which has to be followed in order to collect the amount in question.
For any further information or clarifications, the shareholders are kindly requested to contact the Shareholders Service Department, 11 Sofocleous st, 10235 Athens, phone no 210 6505550.

EUROMEDICA S.A., pursuant to Law no 3371/2005 and the Regulation of the Athens Stock Exchange, informs investors that the company's Board of Directors and the Boards of Directors of GENERAL CLINIC OF THESSALONIKI S.A., of MEDICAL INSTITUTION OF HIGH TECHNOLOGY OF CRETE S.A. and of MEDICAL INSTITUTION OF HIGH TECHNOLOGY OF WESTERN MACEDONIA S.A., at the meeting held on September 28, 2007, resolved the acquisition of GENERAL CLINIC OF THESSALONIKI S.A., of MEDICAL INSTITUTION OF HIGH TECHNOLOGY OF CRETE S.A. and of MEDICAL INSTITUTION OF HIGH TECHNOLOGY OF WESTERN MACEDONIA S.A. by EUROMEDICA S.A., pursuant to the provisions of Codifying Law no 2190/1920 and Law no 2166/1933, as these are in force. The 30th day of September was fixed as the date for the transformation.
The Boards of Directors of the acquired companies shall assign to Certified Auditors BDO Protypos Elegktiki S.A. the drawing up of the relevant report for the ascertainment of the book value of the assets, of the transformation balance sheets. Furthermore, the Boards of Directors of the companies involved shall assign the valuation of the companies to a financial consultant, in order to determine the exchange ratio between EUROMEDICA S.A. and the three acquired companies.
The merger is held under the condition of the approval by the competent corporate bodies and by the competent authorities, as prescribed by the law.

MANDATORY PUBLIC OFFER OF MARFIN INVESTMENT GROUP HOLDINGS S.A. TO THE SHAREHOLDERS OF VIVARTIA INDUSTRIAL AND COMMERCIAL SOCIETE ANONYME OF ALIMENTATION PRODUCTS AND CATERING SERVICES (distinctive title VIVARTIA S.A.) IN RESPECT OF THE ACQUISITION OF THE ENTIRETY OF THEIR COMMON REGISTERED SHARES WITH VOTING RIGHTS, INCLUDING THE SHARES TO DERIVE FROM THE CONVERSION OF ALL EXISTING CONVERTIBLE BONDS AT THE PRICE OF Euro 25.00 PER SHARE IN CASH (pursuant to Law 3461/2006)
MARFIN INVESTMENT GROUP HOLDINGS S.A. (the "Offeror") wishes to announce the following:
1. The Board of Directors of the Capital Market Committee, at its session of Friday, September 28th 2007, approved the Addendum to the Prospectus dated September 6th 2007, which had also been approved by the Board of Directors of the Capital Market Committee, in respect of the Mandatory Public Offer (the "Public Offer") to all holders of common registered shares with voting rights, issued by the company under the name "VIVARTIA INDUSTRIAL AND COMMERCIAL SOCIETE ANONYME OF ALIMENTATION PRODUCTS AND CATERING SERVICES", with the distinctive title "VIVARTIA S.A." (the "Company"), including the shares which will derive from the conversion of the entirety of the existing Convertible Bonds and will have been listed for trading at the Athens Stock Exchange (hereinafter "ASE") by the date of expiration of the Period of Acceptance (the "Shares"), with regard to the purchase of the entirety of the Shares.
2. As of Monday, October 1st 2007 and throughout the Period of Acceptance of the Public Offer (as defined below), the Addendum to the Prospectus and Acceptance Statements of the Public Offer will be available during business hours through the branches of the "NATIONAL BANK OF GREECE S.A." in Greece. As of that same date, the Prospectus will be also available through the branches of "MARFIN EGNATIA BANK S.A.", as well as at the premises of "INVESTMENT BANK OF GREECE S.A." at 24Β Kifissias Avenue, 151 25 Maroussi.
In addition, as of the above-mentioned date The Addendum to the Prospectus will also be available in soft copy at the web site of the Offeror (www.marfininvestmentgroup.com), the Company (www.vivartia.gr) and the Athens Stock Exchange (www.ase.gr).
3. The period of acceptance of the Offer (the "Acceptance Period") has commenced on Tuesday, September 11th 2007 at 08:00 a.m. and ends on Monday, October 8th 2007, at the close of business day of Banks operating in Greece.
The Offeror has authorized the "NATIONAL BANK OF GREECE S.A." to accept the Acceptance Statements as specified in the approved Prospectus of the Public Offer. For more information on the submission of Acceptance Statements, the addressees of the Public Offer may refer to the "NATIONAL BANK OF GREECE S.A.", at the following telephone numbers: 0030 210 3349681, 0030 210 3349655, and 0030 210 3349697.
4. For a briefing on the applicable legislation governing the terms of the Public Offer and the Acceptance Procedure, the addressees of the Public Offer should refer to the approved and published Prospectus.
5. This Announcement is strictly addressed to the addressees of the Public Offer pursuant to the aforementioned above approved and published Prospectus.

SARANTIS Group signed an agreement with the local distributor OLMA Trading Company in Russia, according to which OLMA TC will distribute Sarantis' products, commencing on October 1st 2007. The agreement is in line with the Group's new business model of penetrating the market of Russia and completes the revised business penetration model for the newly established markets of Russia, Turkey and Ukraine.
It is mentioned that in Russia, Sarantis Group is distributing "own portfolio" mass-market fragrances and cosmetics such as C-THRU, BU and STR8.
The above agreement with OLMA Trading Company is expected to benefit the Group by maximizing efficiency in distribution, increasing market shares, and improving profitability. The agreement is also expected to eliminate the inefficiencies of the model used so far, which was based on high fixed operating expenses and lacking mass market penetration. At the same time, through the nationwide distribution of OLMA Trading Company, the Group ensures a high return on advertising and promotion expenses.
OLMA Trading Company was established in 1994 and is one of the leading local distributors in Russia with successful operations in a nation wide scale. OLMA Trading Company maintains a distribution network (warehouses, distribution and order-taking) across the country and employees 180 people.
Furthermore, it is reminded that the Group has already signed a distribution agreement with the local distributor CONRIL in Ukraine on May 11th 2007 and with the local distributor EVYAP in Turkey on September 24th 2007.
Additionally, it is worth mentioning that the Group has already initiated a cost cutting program in the same countries (Turkey, Russia and Ukraine) realizing a large part of the fixed costs and compensations during the 1st semester of 2007. The management of the Group has now completed the cost cutting program in all three countries. The related restructuring cost will be reflected in the 9M 2007 period and will not exceed the management's estimates.
For further assistance, please, do not hesitate to contact the Group's Investor Relation Department (+30 210 61 73 065, Ms. Eleni Pappa)

In response to the Capital Market Commission's Letter numbered 3896/28.09.2007 with respect to an electronic press article regarding the "Contender of the Romanian pharmaceutical company Labormed", ALAPIS SA informs that in order to realize its business plan with the application of a part of the funds raised from the recently completed share capital increase via rights issue, the company assesses various investment opportunities for the participation or acquisition of companies with similar activity. It is in this manner that the company also examines the possibility of acquiring participation in this company.
At this point in time, this specific interest has not yet been realized and consequently any reference to this, is premature. In any case, the company respecting the legislation and the Athens Exchange Rules and Regulations, will promptly announce any regulated information.

Pursuant to the Decision of the Board of Directors on 11/06/2007, during the period from 14/06/2007 to 30/09/2007, a total of 360,000 own company shares out of the 398,000 held by the Company, were sold via the Athens Exchange.
The average selling price amounted to 3.14 Euro per share.
The lowest selling price was set at 3.00 Euro per share.
As a result of the above sales, the Company owns on 30/09/2007 38,000 own shares which represent 0.173% of the total outstanding shares.

Following the successful launching of INTERSPORT stores in Greece, Romania and Bulgaria, Fourlis Group expands its activities in the field of athletic goods in Cyprus.
The first INTERSPORT store in Cyprus, situated in the biggest shopping mall of Nicosia, opened on Thursday 27 September 2007. The store has a selling space of 1,000 square meters offering a big variety of labelled athletic goods as well as all own label products of INTERSPORT.

A) The company, which is listed at the Athens Stock Exchange under the name "ELECTRONIKI ATHINON SA", announces to the investors that the A.S.E. Board of Directors with it's decision dated September 28th 2007, renews the duration of the contract for handling as a market maker for the company's common shares in order to increase their liquidity, with the ASE member "BETA SECURITIES S.A.". The company has contracted an agreement with "BETA SECURITIES S.A." with the following basic terms: 1. BETA SECURITIES S.A. shall transfer market making orders to the ASE Trading System (i.e. simultaneous buy and sell orders) on one's own account for the shares of the company "ELECTRONIKI ATHINON S.A.", according to the special provisions of the existing legislation. 2. The contract of market making has one (1) year duration. 3. Το facilitate the Market Making in view of potential risks undertaken by the market maker, BETA SECURITIES S.A. has contracted an agreement with Mr. Ioannis Stroutsis, major shareholder of the company, which provides for the obligation of the major shareholder to contract share repurchase agreements in the ASE Derivatives Market.
B) Mr. Ioannis Stroutsis, son of Panagiotis, announces to the investors that the A.S.E. Board of Directors with it's decision dated September 28th 2007, renews the duration of the contract for handling as a market maker for the company's common shares in order to increase their liquidity, with the ASE member "BETA SECURITIES S.A.". Το facilitate the Market Making in view of potential risks undertaken by the market maker, BETA SECURITIES S.A. has contracted an agreement with Mr. Ioannis Stroutsis, major shareholder of the Issuer, which provides for the obligation of the major shareholder to contract share repurchase agreements in the ASE Derivatives Market.